Ratings changes for Cisco Systems, Enphase Energy, Autodesk, Amazon.com, Applied Digital, QUALCOMM, Piedmont Lithium and more…Text “MarketBeat” to  68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.  Learn More.
“Kings of Billion-Dollar Mines” Have Found a New Target… (ad)
Some of the smartest investors in the resource industry – the “Kings of Billion-Dollar Mines” – have identified their next big opportunity. Led by two brothers with deep roots in mining, they’ve found themselves in one of the richest gold regions in America. This team has a track record of success and they believe this company is next in line for massive growth.
[Urgent] Starlink Set For The Largest IPO In History? (ad)
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.
Amazon.com (NASDAQ:AMZN) had its price target raised by analysts at Loop Capital (Â Â Â Â ) from $750.00 to $800.00. They now have a “buy” rating on the stock. This represents a 328.3% upside from the current price of $186.78.
Alphabet (NASDAQ:GOOGL) had its price target raised by analysts at Truist Financial Co. (Â Â Â Â ) from $196.00 to $220.00. They now have a “buy” rating on the stock. This represents a 33.2% upside from the current price of $165.19.
CAO Amie Thuener O’toole sold 2,834 shares of the company’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $167.23, for a total value of $473,929.82. Following the sale, the chief accounting officer now owns 26,349 shares in the company, valued at $4,406,343.27. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Director John L. Hennessy sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $164.95, for a total value of $247,425.00. Following the completion of the transaction, the director now directly owns 26,324 shares of the company’s stock, valued at approximately $4,342,143.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
COO Javier Olivan sold 413 shares of the firm’s stock in a transaction that occurred on Friday, October 11th. The stock was sold at an average price of $584.83, for a total transaction of $241,534.79. Following the completion of the sale, the chief operating officer now directly owns 11,533 shares of the company’s stock, valued at approximately $6,744,844.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Cognex (NASDAQ:CGNX) was upgraded by analysts at Stephens from an “equal weight” rating to an “overweight” rating. They now have a $55.00 price target on the stock, up previously from $45.00. This represents a 35.7% upside from the current price of $40.52.
Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $62.00 price target on the stock, up previously from $52.00. This represents a 11.8% upside from the current price of $55.45.
Corteva (NYSE:CTVA) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $67.00 price target on the stock, up previously from $59.00. This represents a 13.9% upside from the current price of $58.81.
W.W. Grainger (NYSE:GWW) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $1,230.00 price target on the stock, up previously from $975.00. This represents a 10.8% upside from the current price of $1,110.41.
NovoCure (NASDAQ:NVCR) was upgraded by analysts at HC Wainwright from a “neutral” rating to a “buy” rating. They now have a $30.00 price target on the stock, up previously from $24.00. This represents a 67.2% upside from the current price of $17.94.
Universal Health Services (NYSE:UHS) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $283.00 price target on the stock, up previously from $220.00. This represents a 18.7% upside from the current price of $238.38.
WESCO International (NYSE:WCC) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $550.00 price target on the stock, up previously from $522.00. This represents a 207.6% upside from the current price of $178.80.
Westlake (NYSE:WLK) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $159.00 price target on the stock, up previously from $151.00. This represents a 11.0% upside from the current price of $143.21.
Carrier Global (NYSE:CARR) was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $85.00 price target on the stock, up previously from $75.00. This represents a 4.2% upside from the current price of $81.54.
CF Industries (NYSE:CF) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $83.00 price target on the stock. This represents a 2.2% downside from the current price of $84.88.
Eastman Chemical (NYSE:EMN) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $119.00 price target on the stock, up previously from $114.00. This represents a 8.2% upside from the current price of $109.98.
Emerson Electric (NYSE:EMR) was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $120.00 price target on the stock, down previously from $135.00. This represents a 8.5% upside from the current price of $110.64.
Enphase Energy (NASDAQ:ENPH) was downgraded by analysts at Susquehanna from a “positive” rating to a “neutral” rating. They now have a $104.00 price target on the stock, down previously from $147.00. This represents a 13.2% upside from the current price of $91.89.
Hawkins (NASDAQ:HWKN) was downgraded by analysts at BWS Financial from a “buy” rating to a “neutral” rating.The current price is $134.42.
Omnicom Group (NYSE:OMC) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $110.00 price target on the stock, up previously from $106.00. This represents a 4.6% upside from the current price of $105.14.
Piedmont Lithium (NASDAQ:PLL) was downgraded by analysts at Macquarie from a “neutral” rating to an “underperform” rating. They now have a $7.80 price target on the stock. This represents a 39.3% downside from the current price of $12.85.
Sitio Royalties (NYSE:STR) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $23.10.
Yum! Brands (NYSE:YUM) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $145.00 price target on the stock, down previously from $156.00. This represents a 9.1% upside from the current price of $132.92.
Autodesk (NASDAQ:ADSK) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $340.00 price target on the stock. This represents a 18.5% upside from the current price of $286.93.
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $51.00 price target on the stock. This represents a 19.3% upside from the current price of $42.74.
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $295.73.
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $27.50.
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at William Blair. They set an “outperform” rating on the stock.The current price is $27.50.
Antero Resources (NYSE:AR) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $33.00 price target on the stock. This represents a 20.6% upside from the current price of $27.37.
Asure Software (NASDAQ:ASUR) is now covered by analysts at Stephens. They set an “overweight” rating and a $13.00 price target on the stock. This represents a 43.3% upside from the current price of $9.07.
BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $44.00 price target on the stock. This represents a 68.2% upside from the current price of $26.16.
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $24.00 price target on the stock. This represents a 12.2% downside from the current price of $27.33.
Burke & Herbert Financial Services (NASDAQ:BHRB) is now covered by analysts at DA Davidson. They set a “buy” rating and a $76.00 price target on the stock. This represents a 19.9% upside from the current price of $63.41.
Brookdale Senior Living (NYSE:BKD) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $8.00 price target on the stock. This represents a 18.7% upside from the current price of $6.74.
Benitec Biopharma (NASDAQ:BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $35.00 price target on the stock. This represents a 240.1% upside from the current price of $10.29.
Maplebear (NASDAQ:CART) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $43.00 price target on the stock. This represents a 2.7% upside from the current price of $41.85.
Chord Energy (NASDAQ:CHRD) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $168.00 price target on the stock. This represents a 31.2% upside from the current price of $128.07.
Civitas Resources (NYSE:CIVI) is now covered by analysts at UBS Group AG. They set a “neutral” rating and a $60.00 price target on the stock. This represents a 19.5% upside from the current price of $50.23.
California Resources (NYSE:CRC) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $68.00 price target on the stock. This represents a 29.2% upside from the current price of $52.64.
Walt Disney (NYSE:DIS) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $95.00 price target on the stock. This represents a 0.7% downside from the current price of $95.67.
EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $10.65.
Freshworks (NASDAQ:FRSH) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $11.00 price target on the stock. This represents a 2.5% downside from the current price of $11.28.
Geron (NASDAQ:GERN) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $6.00 price target on the stock. This represents a 44.2% upside from the current price of $4.16.
Disc Medicine (NASDAQ:IRON) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $47.96.
Keros Therapeutics (NASDAQ:KROS) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $61.01.
Klaviyo (NYSE:KVYO) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $37.00 price target on the stock. This represents a 1.2% upside from the current price of $36.57.
Liquidia (NASDAQ:LQDA) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $30.00 price target on the stock. This represents a 161.3% upside from the current price of $11.48.
Larimar Therapeutics (NASDAQ:LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $26.00 price target on the stock. This represents a 232.5% upside from the current price of $7.82.
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $22.00 price target on the stock. This represents a 102.0% upside from the current price of $10.89.
Paycor HCM (NASDAQ:PYCR) is now covered by analysts at Stephens. They set an “overweight” rating and a $18.00 price target on the stock. This represents a 29.4% upside from the current price of $13.91.
Qualys (NASDAQ:QLYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $135.00 price target on the stock. This represents a 6.7% upside from the current price of $126.51.
Rocket Pharmaceuticals (NASDAQ:RCKT) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $50.00 price target on the stock. This represents a 185.7% upside from the current price of $17.50.
RLI (NYSE:RLI) is now covered by analysts at Oppenheimer Holdings Inc.. They set a “market perform” rating on the stock.The current price is $161.26.
Rapid7 (NASDAQ:RPD) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $50.00 price target on the stock. This represents a 23.9% upside from the current price of $40.34.
Scilex (NASDAQ:SCLX) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $14.00 price target on the stock. This represents a 1345.2% upside from the current price of $0.97.
Tenable (NASDAQ:TENB) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $45.00 price target on the stock. This represents a 6.4% upside from the current price of $42.31.
Travere Therapeutics (NASDAQ:TVTX) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $18.01.
Veracyte (NASDAQ:VCYT) is now covered by analysts at UBS Group AG. They set a “buy” rating and a $43.00 price target on the stock. This represents a 23.5% upside from the current price of $34.81.
Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $40.77.
Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Scotiabank. They set a “sector perform” rating on the stock.The current price is $484.77.
Voyager Therapeutics (NASDAQ:VYGR) is now covered by analysts at Leerink Partners. They set an “outperform” rating and a $15.00 price target on the stock. This represents a 96.1% upside from the current price of $7.65.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
 
 
![[Urgent] Starlink Set For The Largest IPO In History?](https://i0.wp.com/files.admin.agorafinancial.com/images/shutterstock_2144758071.jpg?w=200&ssl=1)
 Apple Inc. (AAPL)
 Amazon.com, Inc. (AMZN)
 
 
 Alphabet Inc. (GOOGL)
 Meta Platforms, Inc. (META)
 Microsoft Co. (MSFT)
